Becton Dickinson & Co.


Market Cap$68.66B

Compare Becton Dickinson

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Becton Dickinson & Co.Becton Dickinson & Co.57.71.5%5%3.50.6
marketMarket Avg49.61.28%30%6.11.1
HealthcareHealthcare Avg32.71.25%19%7.40.9

Earnings Call Q1 2024

February 1, 2024 - AI Summary

BD reported Q1 revenue of $4.7 billion, with organic growth of 2.4%, driven by strong performance in the Interventional segment and solid growth in the Medical segment.
The company raised its FY '24 guidance, increasing the midpoint of its organic revenue growth range to slightly above 5.8% and raising its adjusted diluted EPS guidance to a range of $12.82 to $13.06.
BD's Alaris Infusion System is progressing well, and the company now expects it to contribute at least $200 million in revenue for fiscal '24.
The company saw strong growth in its PureWick chronic incontinence solutions, biologics, and molecular diagnostics platforms.
BD's margin improvement initiatives and cost reduction programs are driving strong operating margins, exceeding expectations in Q1.
The company delivered over $850 million in operating cash flow in Q1 and remains focused on delivering double-digit free cash flow growth for FY '24.

Current Fair Value

7.8% upside

Undervalued by 7.8% based on the discounted cash flow analysis.

Share Statistics

Market cap$68.66 Billion
Enterprise Value$83.59 Billion
Dividend Yield$3.6594 (1.5%)
Earnings per Share$4.2
Outstanding Shares288,902,232
Avg 30 Day Volume1,606,740


Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio57.74
Price to Sales3.52
Price to Book Ratio2.71
Enterprise Value to Revenue4.29
Enterprise Value to EBIT40.21
Enterprise Value to Net Income68
Total Debt to Enterprise0.19
Debt to Equity0.64

Revenue Sources

No data

ESG Score

No data

About Becton, Dickinson And Co.

72,000 employees
CEO: Thomas Polen

BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of hea...